Institute of Clinical Chemistry and Laboratory Medicine, Merkur Teaching Hospital, Zajčeva 19, 10000 Zagreb, Croatia.
Clin Biochem. 2012 Dec;45(18):1694-6. doi: 10.1016/j.clinbiochem.2012.07.115. Epub 2012 Aug 8.
The aim of this study was to compare the performance of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease Study (MDRD) equations in estimating GFR in a large cohort of diabetic patients with various degrees of albuminuria.
In a group of 842 diabetic patients GFR was estimated from standardized creatinine, with MDRD-Study and CKD-EPI equations, and their performance evaluated regarding clinical stages of albuminuria and chronic kidney disease (CKD).
Patients with normoalbuminuria had higher eGFR when calculated by CKD-EPI, than MDRD-Study equation [median (IQR): 103 (91-115) vs 97 (85-113)mL/min/1.73 m(2), P=0.006, n=364], which significantly influenced the prevalence of stage 1 CKD [eGFR>90 mL/min/1.73 m(2): 76.7% (CKD-EPI) vs. 65.1% (MDRD-Study), P=0.005]. There were no differences between the eGFR values derived by two equations in patients with micro- and macroalbuminuria, and more advanced staging of CKD.
CKD-EPI equation might be a superior surrogate marker of GFR in patients with normoalbuminuria and hyperfiltration and could be used as a screening tool for early renal impairment in diabetes. It's validity as a marker of progression of diabetic nephropathy merits further investigation.
本研究旨在比较慢性肾脏病流行病学合作(CKD-EPI)和肾脏病饮食改良研究(MDRD)方程在估计不同程度白蛋白尿的大量糖尿病患者肾小球滤过率(GFR)方面的性能。
在一组 842 例糖尿病患者中,使用标准化肌酐估算 GFR,并用 MDRD-Study 和 CKD-EPI 方程进行评估,并评估其在白蛋白尿和慢性肾脏病(CKD)临床分期方面的表现。
正常白蛋白尿患者的 eGFR 用 CKD-EPI 计算时高于 MDRD-Study 方程[中位数(IQR):103(91-115)vs 97(85-113)mL/min/1.73 m(2),P=0.006,n=364],这显著影响了 1 期 CKD 的患病率[eGFR>90 mL/min/1.73 m(2):76.7%(CKD-EPI)与 65.1%(MDRD-Study),P=0.005]。在微量白蛋白尿和大量白蛋白尿患者以及更晚期 CKD 患者中,两种方程的 eGFR 值之间没有差异。
在正常白蛋白尿和高滤过患者中,CKD-EPI 方程可能是 GFR 的更好替代标志物,可作为糖尿病早期肾损害的筛查工具。它作为糖尿病肾病进展标志物的有效性值得进一步研究。